Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • JustinH
    Junior Member
    • Aug 2014
    • 7

    GO analysis of RNAseq data error

    I am working on GO analysis in arabidopsis and have done the analysis bit and am working on creating the heat map and scatterplot but am getting the error below.

    # Heatmap and scatter plot following GO biological process analysis
    > for (gs in rownames(go.bp$less)[1:3]) {
    + outname = gsub(" |:|/", "_", substr(gs, 12, 100))
    + geneData(genes = ath.sets[[gs]], exprs = exp.fc, ref = NULL,
    + samp = NULL, outname = outname, txt = TRUE, heatmap = TRUE,
    + limit = 3, scatterplot = TRUE)}

    Error in 1:ncol(exprs) : argument of length 0

    It appears to me that the error is in my expression data. I am using the "RNA-seq data Pathway and Gene-set Analysis Workflos as my guide so my expression data comes in from edgeR. If you have ideas please help!
  • sarvidsson
    Senior Member
    • Jan 2015
    • 137

    #2
    What do you get when you type

    Code:
    dim(exp.fc)
    ?
    Last edited by sarvidsson; 02-05-2015, 04:57 AM. Reason: variable name corrected

    Comment

    • hjv
      Junior Member
      • Jul 2015
      • 1

      #3
      I am having the same issue trying to analyse significant GO terms for RNAseq data as per "RNA-seq data Pathway and Gene-set Analysis Workflow".

      The "exp.fc" variable generated has NULL dimensions, which doesn't seem to be a problem for gage but it is a problem for geneData. Does anyone have any idea of what's wrong here?

      Comment

      • Aditi Verma
        Junior Member
        • Mar 2016
        • 3

        #4
        Could you sort the issue out? I have the same problem with 'exp.fc' with null dimensions working fine with gage and with kegg datasets but getting stuck at only geneData. My exp.fc comes from DESeq2 results.

        Comment

        • JustinH
          Junior Member
          • Aug 2014
          • 7

          #5
          I did manage to resolve the issue using the manual from gene data and could graph all genes as a heat map from this
          #Graphing all genes
          geneData(genes = ath.sets[ath.subs$BP], exprs = cpms3, ref = 1:4,
          samp = 5:12, outname = "cpms3", txt = TRUE, heatmap = TRUE,
          limit = 3, scatterplot = TRUE)

          Notice for the gene sets I had to specify my GO gene set to all genes in biological process for it to work and used the "pseudo.counts" from my DGE list for exprs. To graph the actual pathways, I unfortunately couldn't manage to get it to work from the GAGE list and had to graph each pathway individually which i defined as gsX

          gs1 = unique(unlist(ath.sets[ath.subs$BP][rownames(go.bp$greater)[1]]))

          Then I could use geneData and set the genes to gsX and set the outnames myself

          #GO:0006354 DNA-templated transcription, elongation
          geneData(genes = gs1, exprs = cpms3, ref = 1:4,
          samp = 5:8, outname = "DNA-templated trascription", txt = TRUE, heatmap = TRUE, limit = 3, scatterplot = TRUE)

          Hope this helps you I know it took me a while to get it to work

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM
          • GATTACAT
            Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
            by GATTACAT
            Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
            07-01-2026, 11:43 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          24 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          34 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          21 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-07-2026, 11:05 AM
          0 responses
          34 views
          0 reactions
          Last Post SEQadmin2  
          Working...